chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Nasopharyngitis, Swelling, Swelling face
Clinical narrative: Tender; Swollen glands, neck, face, and ear on left side/ glands on left side of neck were swollen; Swollen glands, neck, face, and ear on left side; Swollen glands, neck, face, and ear on left side; Swollen glands, neck, face, and ear on left side; Cold, chills, and felt like freezing to death; Cold, chills, and felt like freezing to death; Felt like drunk driving; Cold, chills, and felt like freezing to death; Severe headache; Dizziness; This is a spontaneous report from a contactable consumer (patient).  A 55-year-old female patient received bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE) at left arm, via an unspecified route of administration on 07Jan2021 11:45 at single dose for covid-19 immunisation. Medical history included rheumatoid arthritis (RA). The patient's concomitant medications were not reported. The patient experienced cold, chills, and felt like freezing to death, felt like drunk driving, severe headache and dizziness on 07Jan2021; swollen glands, neck, face, and ear on left side on 12Jan2021; tender on an unspecified date. The patient received COVID-19 Vaccine on 07Jan2021 at approximately 11:45. She felt like drunk driving: She waited the 15 minutes and was fine. Afterwards, she got into her truck and was literally weaving. Had to really concentrate to keep the truck in a straight line. She had severe headache: Did not go into work on Friday because headache was so bad. It was almost a migraine. She could still feel it, but it was not as severe. Patient known it's five days out, but yesterday (12Jan2021) she got up and glands on left side of neck were swollen. That side of her face and ear was swollen. It was very pronounced. She still swollen today (13Jan2021). Patient stated she worked with dementia and didn't know if she should go into work when she was still swollen and tender. The patient took Benadryl (Lot: P119936, Exp: Apr2023) as Equate Allergy Relief at 25mg, two capsules at night for the reaction. The patient had been taking it every night since she received the COVID-19 Vaccine. Headache was still there. This morning woke up with swollen glands, neck, ear, and face on the left side. The outcome of events "cold, chills, and felt like freezing to death" and dizziness was recovered on 10Jan2021; of event "Felt like drunk driving" was recovered on an unspecified date; of event severe headache was recovering; of event "Swollen glands, neck, face, and ear on left side" was not recovered; of event Tender was unknown.  Information on Lot/Batch number has been requested.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Tender; Swollen glands, neck, face, and ear on left side/ glands on left side of neck were swollen; Swollen glands, neck, face, and ear on left side; Swollen glands, neck, face, and ear on left side; Swollen glands, neck, face, and ear on left side; Cold, chills, and felt like freezing to death; Cold, chills, and felt like freezing to death; Felt like drunk driving; Cold, chills, and felt like freezing to death; Severe headache; Dizziness; This is a spontaneous report from a contactable consumer (patient).  A 55-year-old female patient received bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE) at left arm, via an unspecified route of administration on 07Jan2021 11:45 at single dose for covid-19 immunisation. Medical history included rheumatoid arthritis (RA). The patient's concomitant medications were not reported. The patient experienced cold, chills, and felt like freezing to death, felt like drunk driving, severe headache and dizziness on 07Jan2021; swollen glands, neck, face, and ear on left side on 12Jan2021; tender on an unspecified date. The patient received COVID-19 Vaccine on 07Jan2021 at approximately 11:45. She felt like drunk driving: She waited the 15 minutes and was fine. Afterwards, she got into her truck and was literally weaving. Had to really concentrate to keep the truck in a straight line. She had severe headache: Did not go into work on Friday because headache was so bad. It was almost a migraine. She could still feel it, but it was not as severe. Patient known it's five days out, but yesterday (12Jan2021) she got up and glands on left side of neck were swollen. That side of her face and ear was swollen. It was very pronounced. She still swollen today (13Jan2021). Patient stated she worked with dementia and didn't know if she should go into work when she was still swollen and tender. The patient took Benadryl (Lot: P119936, Exp: Apr2023) as Equate Allergy Relief at 25mg, two capsules at night for the reaction. The patient had been taking it every night since she received the COVID-19 Vaccine. Headache was still there. This morning woke up with swollen glands, neck, ear, and face on the left side. The outcome of events "cold, chills, and felt like freezing to death" and dizziness was recovered on 10Jan2021; of event "Felt like drunk driving" was recovered on an unspecified date; of event severe headache was recovering; of event "Swollen glands, neck, face, and ear on left side" was not recovered; of event Tender was unknown.  Information on Lot/Batch number has been requested.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Oral herpes, Oropharyngeal pain, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Sore arm at injection site; cold sore; Sore throat; This is a spontaneous report from a non-contactable Pharmacist(patient). The 26-year-old male patient received first dose BNT162B2(Covid 19, lot EK5730), via an unspecified route of administration at left arm on 28Dec2020 17:15 at single dose for COVID-19 immunization in hospital.  Medical history included last cold sore was over 2 years ago. There was no other vaccine in four weeks. There was no known allergies, no other medical history.  There were no concomitant medications.  The patient experienced sore throat occurred 2 days after vaccination(30Dec2020), sore arm at injection site, cold sore appearance 8 days after vaccination, both on 05Jan2021. There was no treatment. There was no covid prior vaccination, covid tested post vaccination was Nasal Swab with PCR on 08Jan2021 with negative result.  Outcome of events was recovered in Jan2021 .   No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Chills, Headache, Pyrexia
Clinical narrative: Fever; Headache; Chills; This a spontaneous report from a Pfizer-sponsored program by a contactable consumer (patient). A 77-years-old female patient received first dose of bnt162b2 (Covid-19 vaccine, Batch/lot number: EL3246), via an unspecified route of administration on 07Jan2021 at SINGLE DOSE on left arm for covid-19 immunisation. Medical history included ongoing blood pressure. Concomitant medication included amlodipine (AMLODIPINE), bisoprolol fumarate/hydrochlorothiazide (BISOPROLOL/HYDROCHLOROTHIAZID), both since 2015 and ongoing for blood pressure. The patient experienced fever, headache, chills on 08Jan2021. Everything happened at night time. Her temperatures have been 100.4 and 100.5 degrees. The headache only lasted for a couple of days. It was also only at night. The patient underwent lab tests and procedures which included blood pressure measurement: fine on 12Jan2021, body temperature: 100.4 and 100.5 degrees on an unknown date. The event outcome of fever, headache was not recovered; outcome of chills was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Myalgia, Pyrexia
Clinical narrative: fever 102.7; muscle pain; generalized fatigue; This is a spontaneous report from a non-contactable nurse (patient). An adult female patient received COVID-19 vaccine (UNSPECIFIED TRADE NAME, lot# EK9231), via an unspecified route of administration on 08Jan2021 07:45 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient was not pregnant. If other vaccine in four weeks: No. Twelve hours after the patient received vaccine on 08Jan2021 20:00, the patient developed fever 102.7, muscle pain and generalized fatigue. All symptoms lasted about 24 hours. The patient underwent lab tests and procedures which included body temperature: 102.7 on 08Jan2021. The patient received treatment ibuprofen (MOTRIN) for all the events. If-covid-prior-vaccination: No. If covid tested post vaccination: No. The outcome of all the events was recovered on 09Jan2021. AE was not resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Vaccination site pain
Clinical narrative: Left arm pain in armpit; swollen lymph nodes; led to whole left arm pain; This is spontaneous report from a contactable nurse (patient). A 48-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular on left arm single dose for COVID-19 immunization on 10Jan2021, 09:30 AM, at 48-year-old. Medical history and concomitant medication were not reported. No known allergies. The patient did not have COVID prior vaccination. The patient did not have other vaccine in four weeks. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular on left arm for COVID-19 immunization on 20Dec2020, 05:30 PM, at 48-year-old. On 11Jan2021, 05:00 PM, the patient had left arm pain in armpit with swollen lymph nodes, led to whole left arm pain. No treatment received. The patient was not tested for COVID post vaccination. Action taken for BNT162B2 was not applicable. Outcome of the events was not resolved.   Information on the lot/batch number has been requested.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Pain
Clinical narrative: Extreme body achees; Severe headache; lymphadenopathy in the armpit.; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient (no pregnancy) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly at site of left arm at 10:30 on 11Jan2021 at single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient previously took first dose of BNT162B2 on an unspecified date. The patient experienced extreme body achees, severe headache, lymphadenopathy in the armpit, all at 21:30 on 11Jan2021. Adverse reactions did not result any serious consequences. Facility type vaccine was hospital. No need treatment for adverse event. No covid prior vaccination. No covid tested post vaccination. No known allergies. Other medical history was none. The outcome of events was recovering.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Pain, Pyrexia
Clinical narrative: slight fever; Headache; chills; aches; joint pain; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number-EL3246), via an unspecified route of administration on left arm at 10:30 AM on 07Jan2021 at single dose for COVID-19 immunization. Medical history included thyroid disorder and known allergies: PCN (Penicillin). Concomitant medication included levothyroxine sodium (SYNTHROID), curcumin and vitamins. The patient previously received her first dose of BNT162B2 (lot number=EH9899) on left arm at 10:45 AM on 17Dec2020 for COVID-19 immunization. The patient experienced headache, chills, aches and joint pain with slight fever on 07Jan2021 at 22:00. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for events. The outcome of events was recovered in Jan2021.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Swelling face, Swelling of eyelid
Clinical narrative: eyebrows swollen; area of his eyebrows is swollen and resting right on his eyelids; lymph nodes swollen; This is a spontaneous report from a contactable consumer reported for himself. A 29-year-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730 and expiration date:  31Mar2021), via an unspecified route of administration on arm left on 09Jan2021 11:45 at 0.3mL, single for covid-19 immunisation. The patient medical history reported as none.  There were no concomitant medications. The patient previously took Influenza Quadrivalent (lot number: 294G5 and expiry date: 30Jun2021) at the age of 29-year-old on 20Oct2020 at 0.5mL and never had any problems. The patient having a side effect from the dose he got on Saturday 09Jan2021. He woke up yesterday on 11Jan2021, with his eyebrows swollen, the area of his eyebrows is swollen and resting right on his eyelids. Also reported woke up yesterday on 11Jan2021 with the swollen eyelids and swollen lymph nodes, are a little swollen but have seemed to subside as of today. The outcome of the events swollen eyelid and swollen lymph nodes was recovering, outcome of the other event was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Accidental exposure to product, Exposure via skin contact, Underdose, Vaccination site extravasation
Clinical narrative: felt liquid come out of the injection site; felt liquid come out of the injection site; felt liquid come out of the injection site; did not feel like she got the right amount of vaccine; This is a spontaneous report from a contactable pharmacist (patient). An adult (reported as "30-40") female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 12Jan2021 13:27 at single dose in left deltoid for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on 22Dec2020 in left deltoid for COVID-19 immunization and experienced arm was a little sore. The patient had her 2nd vaccine dose today at 1:27pmET. After she received the dose she felt liquid come out of the injection site. The patient did not feel like she got the right amount of vaccine. The reporter wanted to know if there was any information about measuring titers, or if there was any data on getting a third dose, any information about not being immune and asked if the second dose was not administered properly. The outcome of the events was unknown.  Information on lot/batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Increased appetite, Pruritus
Clinical narrative: increased appetite; Hot flashes; itching; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient (non-pregnant) received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: El3302), via an unspecified route of administration on 11Jan2021 18:45 at single dose on left arm for COVID-19 immunisation. The patient medical history was not reported.  There were no concomitant medications. The patient experienced increased appetite, hot flashes and itching, all on 11Jan2021 20:00 with outcome of not recovered. No treatment was received for the events. No COVID prior vaccination. No COVID tested post vaccination. No COVID tested post vaccination.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy to vaccine, Throat irritation
Clinical narrative: experience allergy symptoms; scratchy throat which is chronic; This is a spontaneous report from contactable pharmacist. A 32-year-old male patient received the second of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular on 11Jan2021 at single dose in left deltoid for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 for COVID-19 immunization. Facility type vaccine was Workplace clinic. It was unknown if other vaccine in four weeks. The patient was seen at SVH COVID Vaccine Clinic today for his second dose of the COVID 19 vaccination. He denied any history of previous adverse reactions to vaccines. He was given the Pfizer vaccination in the left deltoid muscle. On 11Jan2021, during his 30 minutes waiting period after the injection, the patient began to experience allergy symptoms scratchy throat which was chronic. He denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. This provider was notified of patient reaction and he was then assessed in the emergency bay area. Monitored patient for severe reaction symptoms, including but not limited to scratchy throat. No treatment received for the adverse events. The outcome of the events was recovered in Jan2021.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Chills, Investigation, Myalgia
Clinical narrative: muscle pain all over my body; chills; feel the lump in the same area/left armpit; This is a spontaneous report from a contactable consumer. A 34-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 11Jan2021 13:00 (1PM) at a single dose in the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of the vaccination. The patient had no Covid prior to vaccination. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced allergies.  The patient had first dose of bnt162b2 for covid-19 immunization on 21Dec2020, 03:30 PM, in the left arm (number and expiry date not reported) and after the administration of the vaccine, patient discovered a lump on the bottom of the left armpit; felt a lot of discomfort when touching it and it went away around 02Jan2021. Post vaccination, patient was tested for Covid as nasal swab on 07Jan2021 with result as negative. When the second vaccine was administered, patient felt muscle pain all over her body, chills and started to feel the lump in the same area (left armpit) the day after the vaccine was administered (12Jan2021). No treatments received in response to the events reported. The patient did not recover from the events muscle pain all over her body, chills, and lump in the same area (left armpit).   Information on Lot/Batch number has been requested.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Vomiting
Clinical narrative: Sudden abdominal pain 12 hours after vaccination and vomiting.; Sudden abdominal pain 12 hours after vaccination and vomiting; This is a spontaneous report from a non-contactable consumer(patient).  A 26-year-old female patient received first dose BNT162B2, via an unspecified route of administration at left arm on 11Jan2021 14:30 at single dose for COVID-19 immunization . Patient had other medications in two weeks. There was no other vaccine in four weeks. The patient medical history was not reported. There was no covid prior vaccination, no covid tested post vaccination, no Known allergies. The patient experienced sudden abdominal pain 12 hours after vaccination and vomiting on 12Jan2021 03:00 with outcome of recovering. There was no treatment received.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: welts and rashes; welts and rashes; This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is the 1st of the two reports.   A patient of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via an unspecified route of administration on 11Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. The nurse reported that the patient received the second dose of the vaccine on Monday (11Jan2021) and broke out in welts and rashes in Jan2021. The patient went to the ER and was given steroid treatments. The patient did not report respiratory distress. The outcome of the events was unknown   Information on the batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026638 Same reporter/drug; different patient/event.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Fatigue, Headache, Vaccination site erythema, Vaccination site mass
Clinical narrative: Injection site red; Tennis ball sized hard lump; Injection site pain; Injection site Swollen; Facial pain; Fatigue; Headache; This is a spontaneous report from a contactable other Health Professional (patient). A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL1284), intramuscularly in left arm on 10Jan2021 08:00 at single dose for COVID-19 immunization.  The patient medical history was not reported.  Known allergies: No. Other medical history: No. The patient was not pregnant. The patient's concomitant medications were not reported. If other vaccine in four weeks: No. Other medications in two weeks: No. Facility type vaccine: Hospital. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EH9899) on 20Dec2020 for COVID-19 immunization. The patient experienced injection site pain, swollen, red, tennis ball sized hard lump, fatigue, headache, facial pain, all on 11Jan2021 06:00 with outcome of recovering. No treatment received for all the events. If COVID prior vaccination: No. If COVID tested post vaccination: No.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site red; Tennis ball sized hard lump; Injection site pain; Injection site Swollen; Facial pain; Fatigue; Headache; This is a spontaneous report from a contactable other Health Professional (patient). A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL1284), intramuscularly in left arm on 10Jan2021 08:00 at single dose for COVID-19 immunization.  The patient medical history was not reported.  Known allergies: No. Other medical history: No. The patient was not pregnant. The patient's concomitant medications were not reported. If other vaccine in four weeks: No. Other medications in two weeks: No. Facility type vaccine: Hospital. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EH9899) on 20Dec2020 for COVID-19 immunization. The patient experienced injection site pain, swollen, red, tennis ball sized hard lump, fatigue, headache, facial pain, all on 11Jan2021 06:00 with outcome of recovering. No treatment received for all the events. If COVID prior vaccination: No. If COVID tested post vaccination: No.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: the patient got a positve COVID-19 test result; the patient got a positve COVID-19 test result; This is a spontaneous report from a contactable other healthcare professional (hcp). This hcp reported the same events for 2 patients. This is the second of two reports.   A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got a positve COVID-19 test result on 05Jan2021. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.,Linked Report(s) : US-PFIZER INC-2021020999 same drug/events/reporter, different patients
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Myalgia, Neck pain, Peripheral swelling
Clinical narrative: Very swollen and erythematous arm; Very swollen and erythematous arm; chills; severe neck pain; myalgias; This is a spontaneous report from a contactable nurse reported for herself. A 60-year-old female patient (not pregnant) received first dose of bnt162b2 (Lot number: Ek5730), via an unspecified route of administration in left arm on 22Dec2020 11:30 at single dose for COVID-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing (COVID prior vaccination: Yes). There were no concomitant medications. The patient experienced very swollen and erythematous arm, chills, severe neck pain, myalgias, all on 22Dec2020 14:00. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. No treatment given. The outcome of events was resolved. Facility type vaccine: Hospital. No other vaccine in four weeks. No other medications in two weeks. No COVID tested post vaccination. Not known allergies or other medical history.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Nausea
Clinical narrative: 103 degree Fahrenheit fever; chills; nausea; fatigue; headache; This is a spontaneous report from a contactable nurse (patient). This 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Dec2020 08:15 at single dose at left arm for COVID-19 immunization. The patient's medical history included hypertension. No known allergies. The patient's concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C) and Beta blocker. No other vaccine received in four weeks. Patient was not pregnant. Facility type vaccine was hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Patient received second dose on 07Jan2021 19:45 at left arm for COVID-19 immunization. The patient experienced 103 degree Fahrenheit fever, chills, nausea, fatigue, headache for 48 hours on 07Jan2021 19:30. No treatment received. Outcome of the events was recovered.  Information about Lot/Batch has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 103 degree Fahrenheit fever; chills; nausea; fatigue; headache; This is a spontaneous report from a contactable nurse (patient). This 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Dec2020 08:15 at single dose at left arm for COVID-19 immunization. The patient's medical history included hypertension. No known allergies. The patient's concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C) and Beta blocker. No other vaccine received in four weeks. Patient was not pregnant. Facility type vaccine was hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Patient received second dose on 07Jan2021 19:45 at left arm for COVID-19 immunization. The patient experienced 103 degree Fahrenheit fever, chills, nausea, fatigue, headache for 48 hours on 07Jan2021 19:30. No treatment received. Outcome of the events was recovered.  Information about Lot/Batch has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Vaccination site pain
Clinical narrative: Fever; chills; headache; Injection site pain; This is a spontaneous report from a non-contactable physician (patient). A 29-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number= EL3248), intramuscularly on right arm at 09:45 on 11Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient previously received her first dose of BNT162B2 (Lot number= EL1284) intramuscularly on left arm on 22Dec2020 at 20:30 for COVID-19 immunization. The patient experienced injection site pain 6 hours after second dose, fever, chills, headache that started 14 hours after the second dose on 11Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were taken as a result of events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Headache; fever; chills; joint pain; muscle pain; fatigues; This is spontaneous report from a contactable other HCP. A 36-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 09:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient took the first dose on 23Dec2020 at arm left for covid-19 immunization. Medical history included asthma from an unknown date. Allergies to medications included Lamictal and Penicillin. There were no concomitant medications. The facility type vaccine was hospital. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced headache, fever, chills, joint pain, muscle pain, and fatigue on 11Jan2021 with outcome of not recovered. Patient didn't receive treatment for the adverse events. The events were reported as non-serious. Information on the batch number and lot number has been requested.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache; fever; chills; joint pain; muscle pain; fatigues; This is spontaneous report from a contactable other HCP. A 36-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 09:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient took the first dose on 23Dec2020 at arm left for covid-19 immunization. Medical history included asthma from an unknown date. Allergies to medications included Lamictal and Penicillin. There were no concomitant medications. The facility type vaccine was hospital. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced headache, fever, chills, joint pain, muscle pain, and fatigue on 11Jan2021 with outcome of not recovered. Patient didn't receive treatment for the adverse events. The events were reported as non-serious. Information on the batch number and lot number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Insomnia, Pain
Clinical narrative: chills; severe all over body aches especially left arm; headache; sleeplessness; This is a spontaneous report from a contactable other HCP (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el0142) intramuscularly at left arm on 11Jan2021 16:15 at single dose for COVID-19 immunization. Medical history included herniated disk L5 S1. No known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO), ergocalciferol (VITAMIN D), ascorbic acid (VITAMIN C), vitamin b complex (VITAMIN B), cefixime (FLEXERIL), calcium, magnesium, curcuma longa (TURMERIC). The patient previously received first dose of bnt162b2 (lot number: ek5730) intramuscularly at left arm on 21Dec2020 15:45 at single dose for COVID-19 immunization. The patient experienced chills, severe all over body aches especially left arm, headache, sleeplessness, on 11Jan2021 23:30. No treatment received. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The outcome of the events was recovering.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain
Clinical narrative: fatigue; headache; body aches; dizziness; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730, expiry date not reported), intramuscular in the left arm on 23Dec2020 08:00 at single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included caffeine, paracetamol (EXCEDRIN), and paracetamol (TYLENOL). On 23Dec2020, the patient experienced fatigue, headache, body aches and dizziness. No treatment was received for the adverse events. Clinical outcome of the events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Feeling abnormal, Headache, Joint stiffness
Clinical narrative: supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose; supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose; day after 2nd dose all joints felt stiff and extremely sore; day after 2nd dose all joints felt stiff and extremely sore; Incredibly lethargic with headache and brain fog; Incredibly lethargic with headache and brain fog; This is a spontaneous report from a contactable other HCP. This other HCP (Patient) reported for self that the 49-year-old female patient who received second dose of bnt162b2 (BNT162B2), via an unspecified route of administration on Jan2021 06:00 AM on Left arm at single dose for covid-19 immunisation. She is not pregnant. Medical history included known allergies: Augmentin. The patient previously took first dose of bnt162b2 via an unspecified route of administration on Dec2020 06:00 AM on Left arm at single dose for covid-19 immunisation and experienced Supraclavicular lymph node swelled to about pea size after 1st dose. Concomitant medications included in two weeks Sertraline 50 mg, Vitamin D3 5000 IU. Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose. day after 2nd dose all joints felt stiff and extremely sore. Incredibly lethargic with headache and brain fog. The events started from 11Jan2021 04:00 PM. The outcome of the events was recovered with lasting effects. No treatment was received. No COVID prior vaccination. No COVID tested post vaccination.   Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose; supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose; day after 2nd dose all joints felt stiff and extremely sore; day after 2nd dose all joints felt stiff and extremely sore; Incredibly lethargic with headache and brain fog; Incredibly lethargic with headache and brain fog; This is a spontaneous report from a contactable other HCP. This other HCP (Patient) reported for self that the 49-year-old female patient who received second dose of bnt162b2 (BNT162B2), via an unspecified route of administration on Jan2021 06:00 AM on Left arm at single dose for covid-19 immunisation. She is not pregnant. Medical history included known allergies: Augmentin. The patient previously took first dose of bnt162b2 via an unspecified route of administration on Dec2020 06:00 AM on Left arm at single dose for covid-19 immunisation and experienced Supraclavicular lymph node swelled to about pea size after 1st dose. Concomitant medications included in two weeks Sertraline 50 mg, Vitamin D3 5000 IU. Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose. day after 2nd dose all joints felt stiff and extremely sore. Incredibly lethargic with headache and brain fog. The events started from 11Jan2021 04:00 PM. The outcome of the events was recovered with lasting effects. No treatment was received. No COVID prior vaccination. No COVID tested post vaccination.   Information about lot/batch number has been requested.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Moderate soreness at injection site; This is a spontaneous report from a contactable other hcp (patient). A 36-year-old non-pregnant female received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EK 5730), via an unspecified route of administration on 19Dec2020 08:15 at 35 years old at left arm at single dose for covid-19 immunization. Facility type vaccine was doctor's office/urgent care. NO other vaccine in four weeks. Medical history included migraine. No known allergies. Concomitant medication included sumatriptan succinate (IMITREX) 100 mg PRN (As needed) for migraines, ethinylestradiol, norgestimate (SPRINTEC) 28 day. The patient experienced moderate soreness at injection site only for 2 days on an unspecified date. No Covid prior vaccination and covid was not tested post vaccination. The outcome of the event was recovered.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Vaccination site pain
Clinical narrative: muscle pain in the arm where patient got the Pfizer shot; weakness; This is a spontaneous report from a contactable other healthcare professional (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose at arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced muscle pain in the arm where patient got the Pfizer shot, and weakness that faded after a day on an unspecified date. Outcome of event muscle pain in the arm was unknown, and outcome of event weakness was recovered.   No follow-up attempts are possible. Information about Lot/Batch can not be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: felt muscle pain in the arm where they got the Pfizer shot; headache; This is a spontaneous report from a contactable nurse. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced felt muscle pain in the arm where they got the Pfizer shot and headache on an unspecified date. Therapeutic measures were taken as a result of headache included pain killer. Outcome of headache was recovered, other was unknown.  No follow-up attempts are possible. Information about Lot/Batch cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pruritus, Vaccination site erythema, Vaccination site mass
Clinical narrative: warm to touch; Small red, raised, palpable lump warm to touch about the size of the dime by 6pm on same day as injection; Severe burning with injection followed by mild soreness at arm; Severe burning with injection followed by mild soreness at arm; redness; moderate soreness; Itchy; This is a spontaneous report from a contactable Other HCP (patient). This 36-year-old female (not pregnant) patient received 2nd dose of BNT162B2 (Covid vaccine, lot number=EK4176 on 09Jan2021 09:30 AM on Left arm for covid-19 immunization. Medical history was migraines. Concomitant drug was sumatriptan succinate (IMITREX) for migraines, ethinylestradiol norgestimate (SPRINTEC). Historical Vaccine was 1st dose of BNT162B2 on 19Dec2020 08:15 AM (lot number=EK 5730, vaccine location=Left arm) and experienced moderate soreness at injection site only x2 days. It was reported that patient experienced Severe burning with injection followed by mild soreness at arm. Small red, raised, palpable lump warm to touch about the size of the dime by 6pm on same day as injection. 10Jan2021 - moderate soreness. Area remains bright red, raised, warm to touch increased in size to 1"x1" 24 hours after vaccine. 11Jan2021 - 48 hours post vaccine area further enlarged to 2"x2". Moderate soreness. Itchy. Warm to touch. Palpable area extending to edge of redness. 12Jan2021 - 72 hours. No soreness except when touching injection site. Redness less in color and size. No longer itchy. Palpable lump smaller. Quarter size. Treatment was Tylenol. Outcome of the event palpable lump, Redness was recovering, for itchy was recovered, for other events was Not recovered. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site warmth
Clinical narrative: warm to touch; Small red, raised, palpable lump warm to touch about the size of the dime by 6pm on same day as injection; Severe burning with injection followed by mild soreness at arm; Severe burning with injection followed by mild soreness at arm; redness; moderate soreness; Itchy; This is a spontaneous report from a contactable Other HCP (patient). This 36-year-old female (not pregnant) patient received 2nd dose of BNT162B2 (Covid vaccine, lot number=EK4176 on 09Jan2021 09:30 AM on Left arm for covid-19 immunization. Medical history was migraines. Concomitant drug was sumatriptan succinate (IMITREX) for migraines, ethinylestradiol norgestimate (SPRINTEC). Historical Vaccine was 1st dose of BNT162B2 on 19Dec2020 08:15 AM (lot number=EK 5730, vaccine location=Left arm) and experienced moderate soreness at injection site only x2 days. It was reported that patient experienced Severe burning with injection followed by mild soreness at arm. Small red, raised, palpable lump warm to touch about the size of the dime by 6pm on same day as injection. 10Jan2021 - moderate soreness. Area remains bright red, raised, warm to touch increased in size to 1"x1" 24 hours after vaccine. 11Jan2021 - 48 hours post vaccine area further enlarged to 2"x2". Moderate soreness. Itchy. Warm to touch. Palpable area extending to edge of redness. 12Jan2021 - 72 hours. No soreness except when touching injection site. Redness less in color and size. No longer itchy. Palpable lump smaller. Quarter size. Treatment was Tylenol. Outcome of the event palpable lump, Redness was recovering, for itchy was recovered, for other events was Not recovered. No covid prior vaccination. No covid tested post vaccination.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Oral pruritus, Pruritus
Clinical narrative: Minor itching of arms (not at injection site) and around lips.; Minor itching of arms (not at injection site) and around lips.; This is a spontaneous report from a contactable consumer. A 35-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283, expiration date not reported), via an unspecified route of administration at the right arm on 12Jan2021 14:45 at single dose for COVID-19 immunization. Medical history included Latex allergy, chronic migraine, seasonal allergies, and had previous anaphylaxis due to insect stings. Concomitant medication included sumatriptan. The patient previously took Tylenol and experienced allergy. It was reported that the patient experienced minor itching of arms (not at injection site) and around lip. It was reported that the event started shortly after the thirty minute (15:15) wait after injection and ended around an hour after injection (15:45). Patient further reported that she has previous history of anaphylaxis due to insect stings. It was not bad enough to seek treatment and it took a bit to realize that it wasn't just a result of her worrying, but it was noticeable. No hives, no redness. Patient did not feel the need to seek treatment, but she did monitor symptoms until they eased. Vaccine was from a vial with no latex, due to existing minor allergy. No treatment was given to the patient in response to the event. There was no COVID prior to vaccination and no COVID test post vaccination. The patient recovered from the event on 12Jan2021 at 13:45.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Hot flush
Clinical narrative: day 5 of the second shot I woke up extremely hot, felt like my skin  And everything around me was burning/overheating; I also had mild hot flashes after the second vaccine and headaches; I also had mild hot flashes after the second vaccine and headaches; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (pregnant: No)  received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ej1685) intramuscular at left arm on 06Jan2021 10:30 at single dose for COVID-19 immunization. Medical history included Asthma, hypothyroidism, ADD. Concomitant medications were not reported. Patient had known allergies to erythromycin and seasonal allergies. it was unknown if covid prior vaccination. There were other medications in two weeks. Patient used took first dose of BNT162B2 (lot number: Ej1685) on 17Dec2020 at left arm at single dose for COVID-19 immunization and experienced extreme episode of overheating (at night) the first time, got up and almost passed out. It was reported day 5 after both shots patient had an extreme episode of overheating (at night) the first time she got up and almost passed out. day 5 of the second shot she woke up extremely hot, felt like her skin and everything around her was burning, it was inescapable, she had to open a window and wait it out, lasted about 30 minutes. she also had mild hot flashes after the second vaccine and headaches. adverse event start date was 10Jan2021. No covid tested post vaccination. no treatment received for the events. Patient was recovering from the events.